Cemdisiran is under investigation in clinical trial NCT03841448 (A Study of Cemdisiran in Adults With Immunoglobulin a Nephropathy (Igan)).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.